Condition

Polycythemia Vera (PV) clinical trials and research

• 7Clinical trials
• 1New in 30 days
• 7Countries

Newest Polycythemia Vera (PV) clinical trials

All recruiting trials (7)

• Stopping ropeg-interferon in some polycythemia vera patients after responding to treatment

  This study tests whether some people with polycythemia vera who respond to ropeg-interferon can safely stop the therapy.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07886801

• PRT12396 for people with high-risk polycythemia vera or myelofibrosis

  The team will try the oral drug PRT12396 in people with high-risk polycythemia vera or myelofibrosis to find safe doses and look for early signs of benefit.

  Recruiting at 22 sites Phase 1 Prelude Therapeutics Incorporated · Los Angeles, California and 21 other locations · NCT07469891

• Gecacitinib plus pegylated interferon for polycythemia vera

  This study tests whether combining gecacitinib with pegylated interferon can help PV patients reach hematologic remission.

  Recruiting Peking Union Medical College Hospital · Beijing · NCT07445893

• MPN PROGRESSion Registry — tracking symptoms, treatments, and disease progression in people with MPNs.

  Track long-term symptoms, treatments, and disease progression in adults with myeloproliferative neoplasms to see how these conditions evolve over time.

  Recruiting at 2 sites MPN Research Foundation · Chicago, Illinois and 1 other locations · NCT07362225

• Flonoltinib maleate tablets for adults with polycythemia vera (dose-finding and expansion)

  This trial will test whether flonoltinib maleate tablets help adults with polycythemia vera who are resistant or intolerant to hydroxyurea or interferon.

  Recruiting Phase 2 Chengdu Zenitar Biomedical Technology Co., Ltd · Tianjin · NCT07232290

• Using low-dose Methotrexate for treating blood cancers

  This study is testing if adding low-dose Methotrexate to the treatment of blood cancers like Polycythemia Vera and Myelofibrosis can help reduce symptoms and improve spleen size for patients.

  Recruiting Phase 2 Icahn School of Medicine at Mount Sinai · New York, New York · NCT06541249

• Long-term treatment with P1101 for patients with Polycythemia Vera or Essential Thrombocythemia

  This study is testing if a long-term treatment with P1101 can safely help people with Polycythemia Vera or Essential Thrombocythemia who have already tried other treatments.

  Recruiting at 6 sites Phase 3 PharmaEssentia Japan K.K. · Toon-shi, Ehime and 5 other locations · NCT04655092

Related topics

Quick answers

How many Polycythemia Vera (PV) clinical trials are recruiting right now?

7, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 7 countries. The most sites are in United States (4 trials), China (2 trials), Japan (1 trial), Australia (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →